↓ Skip to main content

Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations

Overview of attention for article published in Journal for Immunotherapy of Cancer, December 2018
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news
1 news outlet
twitter
77 tweeters

Citations

dimensions_citation
202 Dimensions

Readers on

mendeley
103 Mendeley